Literature DB >> 26904236

Acetaminophen for febrile patients with suspected infection: potential benefit and further directions.

Shohei Makino1, Moritoki Egi1.   

Abstract

Entities:  

Year:  2016        PMID： 26904236      PMCID： PMC4740171          DOI： 10.3978/j.issn.2072-1439.2016.01.26

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  21 in total

Review 1.  Optimizing the use of blood cultures in the febrile postoperative patient.

Authors:  Andrea T Badillo; Babak Sarani; Stephen R T Evans
Journal:  J Am Coll Surg       Date:  2002-04       Impact factor: 6.113

Review 2.  New directions for induction immunosuppression strategy in solid organ transplantation.

Authors:  Jason S Hawksworth; David Leeser; Rahul M Jindal; Edward Falta; Douglas Tadaki; Eric A Elster
Journal:  Am J Surg       Date:  2009-02-27       Impact factor: 2.565

Review 3.  The adaptive value of fever.

Authors:  M J Kluger; W Kozak; C A Conn; L R Leon; D Soszynski
Journal:  Infect Dis Clin North Am       Date:  1996-03       Impact factor: 5.982

Review 4.  Understanding drug-induced febrile reactions.

Authors:  M K Roush; K M Nelson
Journal:  Am Pharm       Date:  1993-10

5.  The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group.

Authors:  G R Bernard; A P Wheeler; J A Russell; R Schein; W R Summer; K P Steinberg; W J Fulkerson; P E Wright; B W Christman; W D Dupont; S B Higgins; B B Swindell
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

6.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

7.  Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model.

Authors:  J Villar; S P Ribeiro; J B Mullen; M Kuliszewski; M Post; A S Slutsky
Journal:  Crit Care Med       Date:  1994-06       Impact factor: 7.598

8.  Effect of cooling on oxygen consumption in febrile critically ill patients.

Authors:  C A Manthous; J B Hall; D Olson; M Singh; W Chatila; A Pohlman; R Kushner; G A Schmidt; L D Wood
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

9.  Acute heat stress protects rats against endotoxin shock.

Authors:  A J Ryan; S W Flanagan; P L Moseley; C V Gisolfi
Journal:  J Appl Physiol (1985)       Date:  1992-10

10.  Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study.

Authors:  Byung Ho Lee; Daisuke Inui; Gee Young Suh; Jae Yeol Kim; Jae Young Kwon; Jisook Park; Keiichi Tada; Keiji Tanaka; Kenichi Ietsugu; Kenji Uehara; Kentaro Dote; Kimitaka Tajimi; Kiyoshi Morita; Koichi Matsuo; Koji Hoshino; Koji Hosokawa; Kook Hyun Lee; Kyoung Min Lee; Makoto Takatori; Masaji Nishimura; Masamitsu Sanui; Masanori Ito; Moritoki Egi; Naofumi Honda; Naoko Okayama; Nobuaki Shime; Ryosuke Tsuruta; Satoshi Nogami; Seok-Hwa Yoon; Shigeki Fujitani; Shin Ok Koh; Shinhiro Takeda; Shinsuke Saito; Sung Jin Hong; Takeshi Yamamoto; Takeshi Yokoyama; Takuhiro Yamaguchi; Tomoki Nishiyama; Toshiko Igarashi; Yasuyuki Kakihana; Younsuck Koh
Journal:  Crit Care       Date:  2012-02-28       Impact factor: 9.097
View more
  1 in total

1.  Acetaminophen to treat fever in intensive care unit patients with likely infection: a response from the author of the HEAT trial.

Authors:  Paul Young
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.